4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-002617
Chief Operating Officer sold 35,613 shares at an average $60.13 ($2,141,285)
From the SEC's structured data for this filing
Trades in this filing
GIVEN BRUCE D · Chief Operating Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-06 | Sale : show line 1 in the form | −11,847 | $59.57 | $705,726 | 882,759 | D |
| 2020-01-06 | Sale : show line 2 in the form | −22,466 | $60.37 | $1,356,272 | 860,293 | D |
| 2020-01-06 | Sale : show line 3 in the form | −1,300 | $60.99 | $79,287 | 858,993 | D |
| Open-market sales · 35,613 sh · avg $60.13 · $2,141,285 | ||||||
Loading xslF345X03/doc4.xml…